News and Announcements
The Israel-Australia Emerging Company Showcase March 2017
- Published March 27, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Events
Wholesale Investor and affiliation with the Israel Trade Commission hosted their very first event together in Singapore! This event took place on Friday, 24th March 2017.
The event featured 17 Leading, Innovative, Award-Winning Emerging Growth Companies from Australia, Israel and Singapore. Spanning from numerous sectorsfeatured like disruptive SaaS, IoT, virtual reality, artificial intelligence, 3D printing & social experience platforms, award-winning fintech, revolutionary pipeline developer, world’s top VC backed medical devices, world-first healthtech, leading biomedical products, mining opportunities, vertically integrated beef operation & many more.
The Showcase had a full turnout of 120+ professional and sophisticated investors, brokers, fund managers and family offices’ , who were captivated by the compelling presentations.
We thank the investors who joined us and the CEO’s in whom presented. At the end of each event, we are humbled by the innovation, persistence and ambition of our clients.
Our next events will be based in Melbourne later today, Sydney on Thursday and London at the beginning of April followed by the Asia-Pacific Emerging Company Investor Roadshow at the beginning of May.
Click on the button below to find out more about our upcoming events or to register!
Events
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
